Pediatric blood & cancer · 2026
Analysis of Epstein-Barr Virus and Tumor-Derived Circulating Plasma DNA in Children and Young Adults With Classical Hodgkin Lymphoma in East Africa.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chamba Clara, Christopher Heavenlight, Josephat Emmanuel, Sseruyange Julius, Ayitewala Alisen, Dreau Helene, Burns Adam, Otim Isaac, Mapendo Priscus, Mnango Leah, Mremi Alex, Elias Edrick, Achola Caroline, Mawalla William, Chirande Lulu, Kamanga Jacqueline, Legason Ismail, Mahawi Salama, Sandi Godlove, Kashaigili Heronima J, Ntemi Paul Shadrack, Magorosa Erick, Mbwambo Daniel, Ogwang Martin, Vavoulis Dimitrios, Balandya Emmanuel, Cutts Anthony, Mkwizu Eli, Schuh Anna
Аннотация
BACKGROUND: Pediatric Hodgkin lymphoma in sub-Saharan Africa is frequently associated with Epstein-Barr virus (EBV), providing a unique opportunity to investigate the molecular characteristics and clinical significance of EBV-associated disease in an understudied population.
PROCEDURES: We conducted an observational cohort study of 50 children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) in Tanzania and Uganda. Plasma cell-free DNA collected at diagnosis was analyzed for circulating tumor DNA (ctDNA), EBV-derived biomarkers, and somatic mutations. Associations between clinical, molecular, and survival outcomes were assessed using correlation analyses and Cox proportional hazards models.
RESULTS: The median age was 12 years and 62% of participants were male. Most patients presented with advanced-stage disease. ctDNA was detected in 60% of patients with a low mutational burden, while EBV DNA was detected in 92% of cases. Male patients exhibited higher EBV-derived markers and fewer TNFAIP3 and B2M mutations. At a median follow-up of 17.2 months, overall survival was 84% and event-free survival was 50%; male sex and elevated lactate dehydrogenase independently predicted inferior event-free survival.
CONCLUSIONS: These findings reveal a low mutational burden and sex-associated molecular and clinical differences in EBV-positive cHL.
PROCEDURES: We conducted an observational cohort study of 50 children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) in Tanzania and Uganda. Plasma cell-free DNA collected at diagnosis was analyzed for circulating tumor DNA (ctDNA), EBV-derived biomarkers, and somatic mutations. Associations between clinical, molecular, and survival outcomes were assessed using correlation analyses and Cox proportional hazards models.
RESULTS: The median age was 12 years and 62% of participants were male. Most patients presented with advanced-stage disease. ctDNA was detected in 60% of patients with a low mutational burden, while EBV DNA was detected in 92% of cases. Male patients exhibited higher EBV-derived markers and fewer TNFAIP3 and B2M mutations. At a median follow-up of 17.2 months, overall survival was 84% and event-free survival was 50%; male sex and elevated lactate dehydrogenase independently predicted inferior event-free survival.
CONCLUSIONS: These findings reveal a low mutational burden and sex-associated molecular and clinical differences in EBV-positive cHL.